Wayne R. Leifert

ORCID: 0000-0003-0535-7327
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Receptor Mechanisms and Signaling
  • Epigenetics and DNA Methylation
  • Alzheimer's disease research and treatments
  • Advanced biosensing and bioanalysis techniques
  • Fatty Acid Research and Health
  • DNA Repair Mechanisms
  • DNA and Nucleic Acid Chemistry
  • Monoclonal and Polyclonal Antibodies Research
  • Advanced Biosensing Techniques and Applications
  • Salivary Gland Disorders and Functions
  • Cardiac Ischemia and Reperfusion
  • Cholesterol and Lipid Metabolism
  • Molecular Biology Techniques and Applications
  • Cell Image Analysis Techniques
  • Metabolomics and Mass Spectrometry Studies
  • Carcinogens and Genotoxicity Assessment
  • Protein Kinase Regulation and GTPase Signaling
  • Neuropeptides and Animal Physiology
  • Pregnancy and preeclampsia studies
  • Molecular Junctions and Nanostructures
  • Tryptophan and brain disorders
  • RNA Interference and Gene Delivery
  • Folate and B Vitamins Research
  • Single-cell and spatial transcriptomics
  • Antioxidant Activity and Oxidative Stress

CSIRO Health and Biosecurity
2014-2024

The University of Adelaide
2000-2024

Health Sciences and Nutrition
2000-2018

Commonwealth Scientific and Industrial Research Organisation
2007-2017

Animal, Food and Health Sciences
2013-2014

Technologies pour la Santé
2011

Weatherford College
2007

1 The acute effects of n-3 polyunsaturated fatty acids were determined on whole-cell sodium currents recorded in isolated adult rat ventricular myocytes using patch clamp techniques. 2 docosahexaenoic acid (22:6, n-3), eicosapentaenoic (20:5, n-3) and α-linolenic (18:3, dose-dependently blocked the evoked by a voltage step to −30 mV from holding potential −90 with EC50 values 6.0 ± 1.2, 16.2 1.3 26.6 μM, respectively. 3 Docosahexaenoic acid, at 25 μM shifted dependence activation current...

10.1111/j.1469-7793.1999.00671.x article EN The Journal of Physiology 1999-11-01

The metabolomic and proteomic basis of mild cognitive impairment (MCI) Alzheimer’s disease (AD) is poorly understood, the relationships between systemic abnormalities in metabolism AD/MCI pathogenesis unclear. This study compared signature plasma from cognitively normal (CN) dementia patients diagnosed with MCI or AD, to identify specific cellular pathways new biomarkers altered progression disease. We analysed 80 samples individuals as well age- gender-matched CN individuals, by utilising...

10.3390/metabo12100949 article EN cc-by Metabolites 2022-10-06

Abstract Previous studies have shown that mild cognitive impairment (MCI) may be reflective of the early stages more pronounced neurodegenerative disorders such as Alzheimer's disease (AD). There is a need for minimally invasive and inexpensive diagnostic to identify those who exhibit cellular pathology indicative MCI AD risk so they can prioritized primary preventative measures. The hypothesis was approach using cytological markers in isolated buccal mucosa cells used individuals both AD....

10.1002/cyto.a.22453 article EN Cytometry Part A 2014-02-25

The metabolomic and proteomic basis of mild cognitive impairment (MCI) Alzheimer's disease (AD) is poorly understood the relationships between systemic abnormalities in metabolism AD/AMCI pathogenesis are unclear.

10.3233/jad-210283 article EN other-oa Journal of Alzheimer s Disease 2021-06-15

Alzheimer's disease (AD) is a degenerative brain disorder and the most common form of dementia. Minimally invasive approaches are required that combine biomarkers to identify individuals who at risk developing mild cognitive impairment (MCI) AD, appropriately target clinical trials for therapeutic discovery as well lifestyle strategies aimed prevention. Buccal mucosa cells from Australian Imaging, Biomarkers Lifestyle Flagship Study Ageing cohort (n=60) were investigated cytological markers...

10.2174/1567205013666160315112151 article EN Current Alzheimer Research 2016-05-11

Alzheimer’s disease (AD) is an insidious disease. Its distinctive pathology forms over a considerable length of time without symptoms. There need to detect this disease, before even subtle changes occur in cognition. Hallmark AD biomarkers, tau and amyloid-β, have shown promising results CSF blood. However, detecting early these biomarkers others will involve screening wide group healthy, asymptomatic individuals. Saliva feasible alternative. Sample collection economical, non-invasive saliva...

10.3389/fnagi.2022.1019296 article EN cc-by Frontiers in Aging Neuroscience 2022-11-10

Abstract This paper describes a novel strategy to create microarray of G‐protein coupled receptors (GPCRs), an important group membrane proteins both physiologically and pharmacologically. The H 1 ‐histamine receptor the M 2 ‐muscarinic were used as model GPCRs in this study. embedded liposomes created from cellular extracts Spodoptera frugiperda ( Sf9 ) insect cell culture line with its accompanying baculovirus protein insert for overexpression receptors. Once captured onto surface these...

10.1002/pmic.200800539 article EN PROTEOMICS 2009-03-31

Here we describe the adaptation of laser scanning cytometry (LSC) to measure micronuclei (MN) automatically in lymphocytes. MN frequencies were determined irradiated human lymphocytes using cytokinesis-block technique, and results from LSC compared with visual scoring obtained slides cells stained Fast Green 4',6-diamidino-2-phenylindole (DAPI). This fluorescent approach allowed clear identification binucleated detection MN. The dose responses measured visually by showed similar trends...

10.2144/000114239 article EN BioTechniques 2014-12-01
Coming Soon ...